Tech's week of legal pressure: Apple's $5.7bn verdict and Beam's gene editing suit

Apple must pay $5.7bn (about £4.3bn) in damages. A jury at the US District Court for the Southern District of California found the company had used another firm's technology without permission, the BBC reported. The verdict came on Friday 25 September and ranks among the largest patent awards ever handed to a plaintiff suing the iPhone maker.

Taction Technology brought the case. The audio firm makes headphones and gaming headsets. In 2021 it claimed Apple had infringed two patents covering haptics systems, the vibration technology built into devices such as the iPhone and Apple Watch. Taction argued that Apple's improvements to its Taptic Engine, which debuted with the Apple Watch in 2014, infringed patents Taction was issued in 2020. In its complaint, Taction said Apple had been "capitalising on Taction's innovation and success by selling devices that infringe [its] patents" and had used its inventions "without license or authority".

Apple disagrees. The company says it never used Taction's vibration tech and has confirmed it will appeal. "While we thank the jury for their consideration, we strongly disagree with today's verdict and the damages awarded, which are entirely unsupported by the facts," Apple said, according to the BBC. "Apple's Taptic Engine is fundamentally different from Taction's technology, which Taction's own testing of Apple's products confirmed during trial."

The road to that verdict was not straight. A San Diego judge ruled in 2023 that Apple did not infringe Taction's patents, the BBC reported. A federal appeal circuit then took up the case, which led to the September jury trial. Jurors stopped short of finding that Apple had infringed the patents willingly. The award follows a November 2025 order for Apple to pay $634m to medical tech firm Masimo, after a jury found it had infringed a patent for blood-oxygen reading tech.

Beam sues over gene editing tech

On 29 September, Beam Therapeutics sued two Chinese scientists and the two biotech companies where they work, according to Endpoints News. Beam is based in Cambridge, Massachusetts, and develops CRISPR base editing therapies. The suit alleges the defendants stole Beam's gene editing technology. Endpoints did not publish the full complaint, and the available text does not name the individual scientists. The report says the companies are YolTech and Serapha Bio.

The lawsuit adds to a growing set of intellectual property disputes in gene editing, where foundational patents are valuable and contested. Beam filed its action the same week Apple lost its haptic patent case. Both matters turn on how courts assess claims that large companies built products on technology developed elsewhere. Endpoints reported the Beam suit on Tuesday 29 September, two days before a string of other biotech headlines, among them a mid-stage win for Merck's Prometheus drug and updated weight loss data from Zealand and Roche.

Trump signs voluntary AI code

At the White House, President Trump and technology executives signed an AI code of conduct that is only "morally binding" and carries no legal weight, according to Politico, as reported by The Decoder on 30 September. The document requires independent third-party auditors to verify that AI models are "operating as intended". A separate independent board would oversee internal safety checks designed to stop AI models from hacking into systems.

Signatories include Meta CEO Mark Zuckerberg, OpenAI's Greg Brockman, Nvidia's Jensen Huang and Elon Musk, according to Reuters, which The Decoder cited. Zuckerberg called the code a starting point, not a final solution. Trump also proposed creating a ten-member oversight committee, but stressed repeatedly that he does not want to slow AI growth. Critics say a code of conduct without actual legislation is toothless, and similar voluntary commitments have been tried before. Trump also used an executive order to rename AI as "Super Intelligence".

The voluntary nature of the agreement stands in contrast to the court-enforced outcomes in the Apple and Beam disputes. Apple's $5.7bn verdict, if upheld on appeal, would be a financial penalty imposed by a jury rather than a commitment made by a company. Beam's lawsuit seeks a judicial remedy for alleged misappropriation. Neither outcome depends on the goodwill of the parties involved.

Other legal and regulatory pressure

The same week brought other signals that courts and regulators are willing to intervene in technology markets, though many of those developments reached this desk as headlines rather than full articles. Among them: Florida asked a court to block OpenAI from developing new models, according to Politico, and to ban ChatGPT from acting like a person, the Verge reported. Representative Khanna proposed banning self-improving AI, CNBC said. Those items appeared in the 29 September edition of MIT Technology Review's The Download newsletter, which aggregates technology news.

MIT Technology Review also reported that Anthropic's new molecular biology lab claimed its first discovery, with AI agents flagging a previously uncatalogued pattern surrounding an enzyme. The claims angered biologists. Some questioned whether finding the pattern amounted to a discovery at all. One biologist said his team had already discovered the same pattern, which raised questions about whether Anthropic's system had learned from his conversations with Claude. The episode is a reminder that what is novel for AI may be routine for a specialist.

On the antitrust side, the dossier's context headlines point to Google's ongoing battles. A judge ruled Google broke antitrust law in its ad tech business but allowed it to keep the entire ad-tech operation, according to headlines dated 2 and 17 September. Bank of America called the ruling a "major boon" and raised its target price for ad platform Magnite to $38, according to Moomoo. Google has pushed a court to overturn a ruling in the US Department of Justice search monopoly suit, MLex reported on 29 September. Those items are context, not the news peg, and this desk has not independently verified the underlying rulings.

For now, the concrete developments are the Apple verdict, the Beam lawsuit and the White House code. Each will be tested: Apple in an appeal, Beam in court, and the AI code in whether anyone treats a morally binding promise as binding at all.